Hormone replacement therapy (HRT) may offer dual benefits for menopausal women by supporting weight loss efforts and protecting bone density, according to emerging research highlighted by Medical News Today. The findings suggest that HRT could address two of the most common concerns women face during menopause: unexplained weight gain and increased fracture risk due to declining bone mass.
During menopause, declining estrogen levels trigger significant metabolic changes that make weight management more challenging. The same hormonal shifts also accelerate bone density loss, with women losing up to 20% of their bone mass in the five to seven years following menopause. HRT works by supplementing estrogen and sometimes progesterone, potentially counteracting these metabolic disruptions.
The research indicates that women using HRT may find it easier to lose weight or maintain a healthy body composition compared to those not receiving hormone therapy. Additionally, the treatment appears to help preserve bone mineral density, reducing the risk of osteoporosis and related fractures that commonly affect postmenopausal women. These dual benefits could make HRT a valuable tool for managing multiple aspects of menopausal health simultaneously.
For women navigating menopause, these findings reinforce the importance of discussing HRT options with healthcare providers. While hormone therapy isn’t appropriate for everyone—particularly those with certain cardiovascular risks or a history of breast cancer—it may offer significant advantages for suitable candidates. Women concerned about weight changes or bone health during menopause should consult their doctors about whether HRT aligns with their individual health profile and risk factors.
